# Nuago Therapeutics, Inc. — Form D

Nuago Therapeutics, Inc. of CHICAGO, IL, a company, filed a Form D exempt-offering notice with the SEC on 2022-11-08. The offering totals $3.6M, of which $150K was reported sold. Industry: Biotechnology.

## Offering

- Filed: 2022-11-08
- Form: D
- Accession: 0001950101-22-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $3.6M
- Amount sold: $150K
- Remaining: $3.5M
- Investors: 4
- Date of first sale: 2022-10-25
- Revenue range: Decline to Disclose
- SEC file number: 021-464163

## Issuer

- Name: Nuago Therapeutics, Inc.
- CIK: 0001950101
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2020
- Address: 875 NORTH MICHIGAN AVENUE, CHICAGO, IL, 60611
- Phone: 773-401-3203

## Officers, directors & promoters (5)

| Name | Role | Location |
| --- | --- | --- |
| Dr. Andrea E Murmann | Director | Chicago, IL |
| Dr. Marcus E Peter | Director | Chicago, IL |
| Dr. Robert Schickel | Director | Chicago, IL |
| Dr. Andrea E Murmann | Executive Officer | Chicago, IL |
| Dr. Robert Schickel | Executive Officer | Chicago, IL |

## More

- [CIK 1950101 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1950101&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001950101-22-000001.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.